- Sanofi to acquire Synthorx for $2.5 billion MarketWatch
- Sanofi Chief Signals Focus on Cancer With $2.5 Billion Deal The Wall Street Journal
- France’s Sanofi to buy Synthorx for $2.5B Fox Business
- Sanofi to Buy U.S. Biotech Firm for $2.5 Billion in Cancer Push Yahoo Finance
- Sanofi inks $2.5B Synthorx takeover to gain IL-2 cancer drug FierceBiotech
- View full coverage on Google News
Sanofi to acquire Synthorx for $2.5 billion – MarketWatch
